NCT07045428View on ClinicalTrials.gov

68Ga-GP-01 Injection in Solid Tumors Participants

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

November 30, 2026

Conditions

Solid Tumor Malignancies

Interventions

DRUG

68Ga-GP-01 Injection

A certain mass dose of 68Ga-GP-01 will be used in this study, and the radiation dose will be no more than, enabling all participants will receive a radiation dose of 5±2 mCi in the study.

All Listed Sponsors

lead

GrandPharma (China) Co., Ltd.

INDUSTRY